Neuromuscular

Rozanolixizumab Well-Tolerated in Myasthenia Gravis, May Provide Clinical Benefit

November 30, 2020

Article

Rozanolixizumab was associated with reductions in anti-acetylcholine receptor autoantibodies and was well tolerated across 2 dose levels with no new safety findings.

This Week on NeurologyLive — November 30, 2020

November 30, 2020

Article

Here's what is coming soon to NeurologyLive.

Michael Okun, MD: Systemic Issues With Approving Neurological Devices for Rare Diseases

November 29, 2020

Video

The executive director of the Norman Fixel Institute for Neurological Diseases discussed the issues within the current system that prevent approvals for neurologic devices for rare diseases.

NeurologyLive Friday 5 — November 27, 2020

November 27, 2020

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 27, 2020.

Trehalose Granted Orphan Drug Designation for Treatment of Patients with ALS

November 25, 2020

Article

Seelos Therapeutics will soon enroll patients in its phase 2b/3 trial of SLS-005 in amyotrophic lateral sclerosis.

Jennifer Frontera, MD: Mental Health Toll of Pandemic on Frontline Workers

November 25, 2020

Video

The professor of neurology at the NYU Langone Grossman School of Medicine detailed the ways the COVID-19 pandemic impacted mental health of frontline clinicians.